Fennec Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FENC and other ETFs, options, and stocks.About FENC
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients.
FENC Key Statistics
Stock Snapshot
With a market cap of 378.73M, Fennec Pharmaceuticals(FENC) trades at $10.78. The stock has a price-to-earnings ratio of -82.36.
On 2026-09-17, Fennec Pharmaceuticals(FENC) stock traded between a low of $10.74 and a high of $10.99. Shares are currently priced at $10.78, which is +0.4% above the low and -1.9% below the high.
The Fennec Pharmaceuticals(FENC)'s current trading volume is 127.68K, compared to an average daily volume of 243.72K.
In the last year, Fennec Pharmaceuticals(FENC) shares hit a 52-week high of $13.25 and a 52-week low of $5.65.
In the last year, Fennec Pharmaceuticals(FENC) shares hit a 52-week high of $13.25 and a 52-week low of $5.65.
FENC News
Fennec Pharmaceuticals ( (FENC) ) just unveiled an announcement. Fennec Pharmaceuticals reported detailed results from the investigator-initiated Phase 2 STS-J...
Fennec (FENC) announced the oral presentation of detailed results from the investigator-initiated Phase 2 STS-J01 clinical trial evaluating Pedmark for the redu...
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.